{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:52:35Z","timestamp":1786121555711,"version":"build-2736575974"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32271470"],"award-info":[{"award-number":["32271470"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-058"],"award-info":[{"award-number":["2021-I2M-1-058"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jare.2026.07.059","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T15:48:11Z","timestamp":1785167291000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A 3D-bioprinted osteogenic niche model reveals bone microenvironment-driven malignant phenotypes in prostate cancer"],"prefix":"10.1016","author":[{"given":"Chengyi","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingchang","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0449-4223","authenticated-orcid":false,"given":"Yilei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jare.2026.07.059_b0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.jare.2026.07.059_b0010","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-022-01042-7","article-title":"Targeting signaling pathways in prostate cancer: mechanisms and clinical trials","volume":"7","author":"He","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"10.1016\/j.jare.2026.07.059_b0015","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.jare.2026.07.059_b0020","first-page":"232","article-title":"Studies on prostatic cancer. I. the effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate","volume":"22","author":"Huggins","year":"1972","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"10.1016\/j.jare.2026.07.059_b0025","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJMoa2214676","article-title":"Rucaparib or physician's choice in metastatic prostate cancer","volume":"388","author":"Fizazi","year":"2023","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.jare.2026.07.059_b0030","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1200\/JCO.2014.58.2973","article-title":"Nadir testosterone within first year of androgen-deprivation therapy (ADT) predicts for time to castration-resistant progression: a secondary analysis of the PR-7 trial of intermittent versus continuous ADT","volume":"33","author":"Klotz","year":"2015","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.jare.2026.07.059_b0035","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nbt.2958","article-title":"3D bioprinting of tissues and organs","volume":"32","author":"Murphy","year":"2014","journal-title":"Nat Biotechnol"},{"issue":"4","key":"10.1016\/j.jare.2026.07.059_b0040","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/7\/4\/045012","article-title":"Three-dimensional bioprinting of complex cell laden alginate hydrogel structures","volume":"7","author":"Tabriz","year":"2015","journal-title":"Biofabrication"},{"issue":"1","key":"10.1016\/j.jare.2026.07.059_b0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41572-020-00216-3","article-title":"Bone metastases","volume":"6","author":"Coleman","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"10","key":"10.1016\/j.jare.2026.07.059_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20102587","article-title":"Prostate cancer and bone metastases: the underlying mechanisms","volume":"20","author":"Wong","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.jare.2026.07.059_b0055","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nrclinonc.2011.67","article-title":"Bone metastasis in prostate cancer: emerging therapeutic strategies","volume":"8","author":"Sturge","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"10.1016\/j.jare.2026.07.059_b0060","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nrurol.2015.90","article-title":"Targeting bone metastases in prostate cancer: improving clinical outcome","volume":"12","author":"Body","year":"2015","journal-title":"Nat Rev Urol"},{"issue":"1","key":"10.1016\/j.jare.2026.07.059_b0065","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13045-019-0829-z","article-title":"Applications of patient-derived tumor xenograft models and tumor organoids","volume":"13","author":"Yoshida","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"12","key":"10.1016\/j.jare.2026.07.059_b0070","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41568-022-00514-w","article-title":"3D bioprinted cancer models: from basic biology to drug development","volume":"22","author":"Neufeld","year":"2022","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"10.1016\/j.jare.2026.07.059_b0075","doi-asserted-by":"crossref","first-page":"364","DOI":"10.18063\/ijb.v7i3.364","article-title":"Developments and opportunities for 3D bioprinted organoids","volume":"7","author":"Ren","year":"2021","journal-title":"Int J Bioprint"},{"issue":"5","key":"10.1016\/j.jare.2026.07.059_b0080","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41578-021-00279-y","article-title":"Engineering organoids","volume":"6","author":"Hofer","year":"2021","journal-title":"Nat Rev Mater"},{"issue":"1","key":"10.1016\/j.jare.2026.07.059_b0085","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s13046-016-0462-4","article-title":"Patient-derived xenografts: a relevant preclinical model for drug development","volume":"35","author":"Pompili","year":"2016","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.jare.2026.07.059_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121566","article-title":"Shedding light on 3D printing: printing photo-crosslinkable constructs for tissue engineering","volume":"286","author":"Zhang","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.jare.2026.07.059_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120416","article-title":"Three-dimensional bio-printing of primary human hepatocellular carcinoma for personalized medicine","volume":"265","author":"Xie","year":"2021","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.jare.2026.07.059_b0100","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/gutjnl-2019-319960","article-title":"Three-dimensional bioprinted hepatorganoids prolong survival of mice with liver failure","volume":"70","author":"Yang","year":"2021","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.jare.2026.07.059_b0105","first-page":"1809","article-title":"LNCaP model of human prostatic carcinoma","volume":"43","author":"Horoszewicz","year":"1983","journal-title":"Cancer Res"},{"issue":"15","key":"10.1016\/j.jare.2026.07.059_b0110","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/pros.21383","article-title":"PC3 is a cell line characteristic of prostatic small cell carcinoma","volume":"71","author":"Tai","year":"2011","journal-title":"Prostate"},{"issue":"269","key":"10.1016\/j.jare.2026.07.059_b0115","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010563","article-title":"Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: results from a pilot clinical study","volume":"7","author":"Schweizer","year":"2015","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.jare.2026.07.059_b0120","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/pros.23459","article-title":"Serum-free complete medium, an alternative medium to mimic androgen deprivation in human prostate cancer cell line models","volume":"78","author":"Fiandalo","year":"2018","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.jare.2026.07.059_b0125","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ccr.2006.09.005","article-title":"Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators","volume":"10","author":"Hieronymus","year":"2006","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.jare.2026.07.059_b0130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cell.2009.04.056","article-title":"Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer","volume":"138","author":"Wang","year":"2009","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jare.2026.07.059_b0135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13287-016-0444-7","article-title":"Characteristics of human adipose derived stem cells in scleroderma in comparison to sex and age matched normal controls: implications for regenerative medicine","volume":"8","author":"Griffin","year":"2017","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"10.1016\/j.jare.2026.07.059_b0140","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/MAT.0b013e31802deb2d","article-title":"Cytoskeletal changes of mesenchymal stem cells during differentiation","volume":"53","author":"Yourek","year":"2007","journal-title":"ASAIO J"},{"issue":"11","key":"10.1016\/j.jare.2026.07.059_b0145","doi-asserted-by":"crossref","DOI":"10.3390\/biom14111392","article-title":"\u201cA friend among strangers\u201d or the ambiguous roles of Runx2","volume":"14","author":"Azarkina","year":"2024","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.jare.2026.07.059_b0150","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41421-024-00689-6","article-title":"Cell signaling and transcriptional regulation of osteoblast lineage commitment, differentiation, bone formation, and homeostasis","volume":"10","author":"Zhu","year":"2024","journal-title":"Cell Discov"},{"issue":"7","key":"10.1016\/j.jare.2026.07.059_b0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011917","article-title":"Retinoic acids potentiate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells","volume":"5","author":"Zhang","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jare.2026.07.059_b0160","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1186\/s12885-016-2826-8","article-title":"Molecular profile of 5-fluorouracil pathway genes in colorectal carcinoma","volume":"16","author":"Kunicka","year":"2016","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.jare.2026.07.059_b0165","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4161\/cbt.28413","article-title":"dCK expression correlates with 5-fluorouracil efficacy and HuR cytoplasmic expression in pancreatic cancer: a dual-institutional follow-up with the RTOG 9704 trial","volume":"15","author":"McAllister","year":"2014","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.jare.2026.07.059_b0170","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1158\/1538-7445.AM2024-1501","article-title":"Abstract 1501: engineering tissue models to elucidate prostate cancer bone metastasis dynamics","volume":"84","author":"Han","year":"2024","journal-title":"Cancer Res"},{"issue":"23","key":"10.1016\/j.jare.2026.07.059_b0175","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1158\/0008-5472.CAN-08-2492","article-title":"Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis","volume":"68","author":"Sung","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.jare.2026.07.059_b0180","article-title":"Exploring the function of stromal cells in cholangiocarcinoma by three-dimensional bioprinting immune microenvironment model","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jare.2026.07.059_b0185","doi-asserted-by":"crossref","unstructured":"Navone NM, Labanca E. Modeling cancer metastasis. Molecular and translational medicine. Cham: Springer International Publishing; 2017. p. 93-114.","DOI":"10.1007\/978-3-319-55825-7_7"},{"issue":"12","key":"10.1016\/j.jare.2026.07.059_b0190","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/cac2.12224","article-title":"Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy","volume":"41","author":"Qu","year":"2021","journal-title":"Cancer Commun (Lond)"},{"issue":"6194","key":"10.1016\/j.jare.2026.07.059_b0195","doi-asserted-by":"crossref","DOI":"10.1126\/science.1247125","article-title":"Organogenesis in a dish: modeling development and disease using organoid technologies","volume":"345","author":"Lancaster","year":"2014","journal-title":"Science"},{"issue":"15","key":"10.1016\/j.jare.2026.07.059_b0200","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1016\/j.cell.2022.06.051","article-title":"Human organoids: new strategies and methods for analyzing human development and disease","volume":"185","author":"Corsini","year":"2022","journal-title":"Cell"},{"issue":"32","key":"10.1016\/j.jare.2026.07.059_b0205","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1038\/s41388-023-02776-6","article-title":"Engineering prostate cancer in vitro: what does it take?","volume":"42","author":"Buskin","year":"2023","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.jare.2026.07.059_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101015","article-title":"3D Bioprinted cancer models: revolutionizing personalized cancer therapy","volume":"14","author":"Augustine","year":"2021","journal-title":"Transl Oncol"},{"issue":"3","key":"10.1016\/j.jare.2026.07.059_b0215","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3390\/jfb2030119","article-title":"Controlled positioning of cells in biomaterials-approaches towards 3D tissue printing","volume":"2","author":"Wust","year":"2011","journal-title":"J Funct Biomater"},{"key":"10.1016\/j.jare.2026.07.059_b0220","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1171141","article-title":"Combining preclinical tools and models to unravel tumor complexity: jump into the next dimension","volume":"14","author":"Miserocchi","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jare.2026.07.059_b0225","first-page":"465","article-title":"Minimally invasive bioprinting for in situ liver regeneration","volume":"26","author":"Yang","year":"2023","journal-title":"Bioact Mater"},{"issue":"27","key":"10.1016\/j.jare.2026.07.059_b0230","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg2564","article-title":"In vitro engineering of a bone metastases model allows for study of the effects of antiandrogen therapies in advanced prostate cancer","volume":"7","author":"Bock","year":"2021","journal-title":"Sci Adv"},{"issue":"4","key":"10.1016\/j.jare.2026.07.059_b0235","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/aba0c3","article-title":"Bioprinting of patient-derived in vitro intrahepatic cholangiocarcinoma tumor model: establishment, evaluation and anti-cancer drug testing","volume":"12","author":"Mao","year":"2020","journal-title":"Biofabrication"},{"issue":"2","key":"10.1016\/j.jare.2026.07.059_b0240","article-title":"Prediction of clinical precision chemotherapy by patient-derived 3D bioprinting models of colorectal cancer and its liver metastases","volume":"11","author":"Sun","year":"2024","journal-title":"Adv Sci (Weinh)"},{"issue":"3","key":"10.1016\/j.jare.2026.07.059_b0245","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/acd960","article-title":"3D bioprinting of multi-cellular tumor microenvironment for prostate cancer metastasis","volume":"15","author":"Xu","year":"2023","journal-title":"Biofabrication"},{"issue":"1","key":"10.1016\/j.jare.2026.07.059_b0250","doi-asserted-by":"crossref","first-page":"14979","DOI":"10.1038\/s41598-019-50577-3","article-title":"Macrofluidic recirculating model of skeletal metastasis","volume":"9","author":"Osawa","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jare.2026.07.059_b0255","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bone.2014.02.001","article-title":"Paracrine interactions between LNCaP prostate cancer cells and bioengineered bone in 3D in vitro culture reflect molecular changes during bone metastasis","volume":"63","author":"Sieh","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.jare.2026.07.059_b0260","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.biomaterials.2015.07.019","article-title":"The use of collagen-based scaffolds to simulate prostate cancer bone metastases with potential for evaluating delivery of nanoparticulate gene therapeutics","volume":"66","author":"Fitzgerald","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.jare.2026.07.059_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119402","article-title":"Microenvironment engineering of osteoblastic bone metastases reveals osteomimicry of patient-derived prostate cancer xenografts","volume":"220","author":"Shokoohmand","year":"2019","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.jare.2026.07.059_b0270","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1210\/er.2012-1026","article-title":"The osteocyte: an endocrine cell and more","volume":"34","author":"Dallas","year":"2013","journal-title":"Endocr Rev"},{"key":"10.1016\/j.jare.2026.07.059_b0275","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.addr.2021.05.007","article-title":"Pharmaceutical electrospinning and 3D printing scaffold design for bone regeneration","volume":"174","author":"Wang","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1016\/j.jare.2026.07.059_b0280","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22031404","article-title":"The Progress of Stem Cell Technology for Skeletal Regeneration","volume":"22","author":"Tani","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2026.07.059_b0285","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1478-811X-9-12","article-title":"Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC","volume":"9","author":"Hass","year":"2011","journal-title":"Cell Commun Signal"},{"issue":"1","key":"10.1016\/j.jare.2026.07.059_b0290","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13287-020-01661-3","article-title":"A comparison of the use of adipose-derived and bone marrow-derived stem cells for peripheral nerve regeneration in vitro and in vivo","volume":"11","author":"Zhou","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"10.1016\/j.jare.2026.07.059_b0295","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00441-006-0308-z","article-title":"Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle","volume":"327","author":"Yoshimura","year":"2007","journal-title":"Cell Tissue Res"},{"issue":"1","key":"10.1016\/j.jare.2026.07.059_b0300","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3892\/ijmm.2015.2413","article-title":"Comparison of molecular profiles of human mesenchymal stem cells derived from bone marrow, umbilical cord blood, placenta and adipose tissue","volume":"37","author":"Heo","year":"2016","journal-title":"Int J Mol Med"},{"issue":"4","key":"10.1016\/j.jare.2026.07.059_b0305","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s12015-009-9094-9","article-title":"Embryonic stem cell marker expression pattern in human mesenchymal stem cells derived from bone marrow, adipose tissue, heart and dermis","volume":"5","author":"Riekstina","year":"2009","journal-title":"Stem Cell Rev Rep"},{"key":"10.1016\/j.jare.2026.07.059_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.110312","article-title":"Electrical stimulation-induced osteogenesis of human adipose derived stem cells using a conductive graphene-cellulose scaffold","volume":"107","author":"Li","year":"2020","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/j.jare.2026.07.059_b0315","first-page":"1273","article-title":"Layer-by-layer paper-stacking nanofibrous membranes to deliver adipose-derived stem cells for bone regeneration","volume":"10","author":"Wan","year":"2015","journal-title":"Int J Nanomed"},{"issue":"11","key":"10.1016\/j.jare.2026.07.059_b0320","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115409","article-title":"Osteogenesis of 3D-printed PCL\/TCP\/bdECM scaffold using adipose-derived stem cells aggregates; an experimental study in the canine mandible","volume":"22","author":"Lee","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.jare.2026.07.059_b0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040217","article-title":"Phenotypic characterization of prostate cancer LNCaP cells cultured within a bioengineered microenvironment","volume":"7","author":"Sieh","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.jare.2026.07.059_b0330","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1158\/0008-5472.CAN-18-2812","article-title":"Activation of MAPK signaling by CXCR7 leads to enzalutamide resistance in prostate cancer","volume":"79","author":"Li","year":"2019","journal-title":"Cancer Res"},{"issue":"52","key":"10.1016\/j.jare.2026.07.059_b0335","doi-asserted-by":"crossref","first-page":"7333","DOI":"10.1038\/sj.onc.1210536","article-title":"HIF-1 and NF-kappaB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells","volume":"26","author":"Maxwell","year":"2007","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.jare.2026.07.059_b0340","doi-asserted-by":"crossref","first-page":"12263","DOI":"10.1038\/s41598-019-48701-4","article-title":"A biomimetic 3D model of hypoxia-driven cancer progression","volume":"9","author":"Liverani","year":"2019","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.jare.2026.07.059_b0345","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0959-8049(98)00228-7","article-title":"Etoposide: four decades of development of a topoisomerase II inhibitor","volume":"34","author":"Hande","year":"1998","journal-title":"Eur J Cancer"},{"issue":"8","key":"10.1016\/j.jare.2026.07.059_b0350","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.3390\/molecules13081551","article-title":"5-Fluorouracil: mechanisms of resistance and reversal strategies","volume":"13","author":"Zhang","year":"2008","journal-title":"Molecules"},{"key":"10.1016\/j.jare.2026.07.059_b0355","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"10.1016\/j.jare.2026.07.059_b0360","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S1470-2045(17)30469-2","article-title":"Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1\/2 mutation (SOLO2\/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial","volume":"18","author":"Pujade-Lauraine","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jare.2026.07.059_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101789","article-title":"Evaluating the defect targeting effects and osteogenesis promoting capacity of exosomes from 2D- and 3D-cultured human adipose-derived stem cells","volume":"49","author":"Chen","year":"2023","journal-title":"Nano Today"},{"key":"10.1016\/j.jare.2026.07.059_b0370","doi-asserted-by":"crossref","DOI":"10.1590\/1678-7757-2018-0317","article-title":"Retinoic acid increases the effect of bone morphogenetic protein type 2 on osteogenic differentiation of human adipose-derived stem cells","volume":"27","author":"Cruz","year":"2019","journal-title":"J Appl Oral Sci"},{"issue":"2","key":"10.1016\/j.jare.2026.07.059_b0375","doi-asserted-by":"crossref","DOI":"10.3390\/cells14020135","article-title":"Deciphering the transcriptional metabolic profile of adipose-derived stem cells during osteogenic differentiation and epigenetic drug treatment","volume":"14","author":"Gerini","year":"2025","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.jare.2026.07.059_b0380","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00198-004-1649-7","article-title":"Steroid effects on osteogenesis through mesenchymal cell gene expression","volume":"16","author":"Li","year":"2005","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.jare.2026.07.059_b0385","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1196\/annals.1402.081","article-title":"Transcriptional regulation of osteoblasts","volume":"1116","author":"Franceschi","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"11","key":"10.1016\/j.jare.2026.07.059_b0390","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1158\/0008-5472.CAN-14-2493","article-title":"Tumor-induced pressure in the bone microenvironment causes osteocytes to promote the growth of prostate cancer bone metastases","volume":"75","author":"Sottnik","year":"2015","journal-title":"Cancer Res"},{"issue":"31","key":"10.1016\/j.jare.2026.07.059_b0395","doi-asserted-by":"crossref","first-page":"7928","DOI":"10.1016\/j.biomaterials.2010.06.055","article-title":"Mineralized human primary osteoblast matrices as a model system to analyse interactions of prostate cancer cells with the bone microenvironment","volume":"31","author":"Reichert","year":"2010","journal-title":"Biomaterials"},{"issue":"3","key":"10.1016\/j.jare.2026.07.059_b0400","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s12195-017-0483-x","article-title":"Investigating the mechanobiology of cancer cell-ECM interaction through collagen-based 3D scaffolds","volume":"10","author":"Liverani","year":"2017","journal-title":"Cell Mol Bioeng"},{"key":"10.1016\/j.jare.2026.07.059_b0405","article-title":"Development of a human preclinical model of osteoclastogenesis from peripheral blood monocytes co-cultured with breast cancer cell lines","volume":"127","author":"Mercatali","year":"2017","journal-title":"J Vis Exp"},{"issue":"11","key":"10.1016\/j.jare.2026.07.059_b0410","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ccell.2021.09.005","article-title":"Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment","volume":"39","author":"Kfoury","year":"2021","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.jare.2026.07.059_b0415","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.trecan.2020.09.006","article-title":"Emerging players in prostate cancer-bone niche communication","volume":"7","author":"Furesi","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jare.2026.07.059_b0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbiosy.2025.100125","article-title":"Advancing 3D scaffold models for metastatic prostate cancer in bone: materials, manufacture, and future perspectives","volume":"20","author":"Dozzo","year":"2025","journal-title":"Biomater Biosystems"},{"issue":"4","key":"10.1016\/j.jare.2026.07.059_b0425","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/ab97a1","article-title":"Direct-write 3D printing and characterization of a GelMA-based biomaterial for intracorporeal tissue","volume":"12","author":"Adib","year":"2020","journal-title":"Biofabrication"},{"issue":"4","key":"10.1016\/j.jare.2026.07.059_b0430","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.gpb.2021.08.001","article-title":"The Genome sequence archive family: toward explosive data growth and diverse data types","volume":"19","author":"Chen","year":"2021","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"10.1016\/j.jare.2026.07.059_b0435","unstructured":"Members C-N, Partners. Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2022. Nucleic Acids Res 2022;50(D1):D27-D38."}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123226006041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123226006041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T04:55:46Z","timestamp":1786078546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123226006041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":87,"alternative-id":["S2090123226006041"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2026.07.059","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A 3D-bioprinted osteogenic niche model reveals bone microenvironment-driven malignant phenotypes in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2026.07.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}